BAFNA PHARMACEUTICALS
Back to Balance Sheet
|
BAFNA PHARMACEUTICALS Last 5 Year Deferred Tax Assets / Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | - | - | - | - | - |
What is the latest Deferred Tax Assets / Liabilities ratio of BAFNA PHARMACEUTICALS ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2025 | - |
| Mar2024 | - |
| Mar2023 | - |
| Mar2022 | - |
| Mar2021 | - |
How is Deferred Tax Assets / Liabilities of BAFNA PHARMACEUTICALS Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | - | 0 | |
| Mar2024 | - | 0 | |
| Mar2023 | - | 0 | |
| Mar2022 | - | 0 | |
| Mar2021 | - | - | |
Compare Deferred Tax Assets / Liabilities of peers of BAFNA PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BAFNA PHARMACEUTICALS | ₹284.2 Cr | -0% | -19.4% | 45.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹408,559.0 Cr | 1.2% | -5.3% | -5.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹164,827.0 Cr | -3.9% | -6% | 11.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹136,942.0 Cr | 0.9% | 3.7% | 20.5% | Stock Analytics | |
| CIPLA | ₹106,825.0 Cr | -1.2% | -12.6% | -6.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,077.0 Cr | -3.4% | -5.7% | 0.3% | Stock Analytics | |
BAFNA PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BAFNA PHARMACEUTICALS | -0% |
-19.4% |
45.2% |
| SENSEX | 1.7% |
-1.7% |
10.3% |
You may also like the below Video Courses